The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The prenatal testing and newborn screening market will increase from $5.04 billion in 2022 to $5.65 billion in 2023, with a 12.2% CAGR. By 2027, it’s projected to reach $8.87 billion, growing at an 11.9% CAGR.

North America held the largest prenatal testing and newborn screening market share, and Western Europe was the fastest-growing region in 2022.

Prenatal Testing And Newborn Screening Market Driver
High infant genetic disease rates fuel prenatal testing & newborn screening market. Genetic diseases encompass Thalassemia, Sickle Cell Anemia, Haemophilia, Cystic Fibrosis, Tay Sachs, Fragile X, and Huntington’s. Sickle cell anemia is prevalent among those with African, American, Cuban, Central American, Saudi Arabian, and Indian ancestry. In 2020, the CDC reported 5,568 Trisomy 21 cases (Down syndrome), 1,187 Trisomy 18 cases (Edwards syndrome), and 531 Trisomy 13 cases (Patau syndrome). Infant genetic disease prevalence drives demand for this market’s growth.

View More On The Prenatal Testing And Newborn Screening Market Report 2023 – https://www.thebusinessresearchcompany.com/report/prenatal-testing-and-newborn-screening-global-market-report

Prominent Prenatal Testing And Newborn Screening Market Trend
Machine learning and artificial intelligence are gradually gaining traction in the prenatal testing and newborn screening sector. AI simulates human intelligence in machines, while machine learning is a subset of AI. These technologies enable in-depth data analysis, disease insights, and accurate tissue sample evaluations. For instance, in September 2021, Sema4, a U.S.-based AI-driven genomic and clinical data intelligence platform, introduced Sema4 Elements, digital genetic solutions that employ artificial intelligence to enhance patient and provider services in reproductive and generational health journeys.

Prenatal Testing And Newborn Screening Market Prominent Players
Major players in the prenatal testing and newborn screening market are PerkinElmer, Progenity, Laboratory Corporation of America Holdings (Sequenom), Natera, Invitae, Centogene, Cradle Genomics, Roche Diagnostics, Quest Diagnostics and Baebies.

Request A Sample Of The Global Prenatal Testing And Newborn Screening Market Report 2023:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3350&type=smp

Key Prenatal Testing And Newborn Screening Market Segments
The global prenatal testing and newborn screening market is segmented –
1) By Diagnostic Type: Non-Invasive, Invasive
2) By Technology: Screening Technology, Diagnostic Technology
3) By End user: Hospitals, Diagnostic centers

The Prenatal Testing And Newborn Screening Global Market Report 2023  provides a comprehensive overview on the prenatal testing and newborn screening market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the prenatal testing and newborn screening market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

View More Related Reports –
Testing, Inspection, And Certification Global Market Report 2023
Prenatal DNA Sequencing Global Market Report 2023
Newborn Eye Imaging Systems Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model